Analysis of the mergers & acquisitions activity in chemical distribution under the impression of the pandemic situation and how it might develop going forward.
After German Covid-19 vaccine maufacturer BioNTech announced earlier this week that it plans to expand into Asia with a new plant in Singapore, news has emerged that US...
US biotech Novavax has again delayed filing for approval of its protein-based Covid-19 vaccine at least until July this year, citing issues related to an assay needed to...
In a nutshell, reaching sustainability has become a key aspect for chemical companies and adjacent businesses along the product chain with a high entry hurdle for...
In two major new investments at its sites in Visp, Switzerland, and Portsmouth New Hampshire, USA, Swiss CDMO Lonza said it will spend 850 million Swiss francs to expand...
The long simmering discussion over whether manufacturers of Covid-19 vaccines should waive their intellectual property (IP) rights in hope of giving more people access to...
Arkema has completed the sale of its PMMA business to US plastics and rubber producer Trinseo, a deal announced in December 2020. The French chemical company said the...
US Covid-19 vaccine manufacturer Moderna said it is planning to make major renovations at its Norwood, Massachusetts, mRNA production site with the aim of more than...